Cargando…

Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors

The widespread transmission of SARS-CoV-2 has sparked alarm worldwide. Attaining the best drugs to treat COVID-19 at the shortest possible time is one of the most critical issues in this urgent situation. Molecular docking investigation of the therapeutic potential of marketed drugs is a fast and co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sattari, Ahmad, Ramazani, Ali, Aghahosseini, Hamideh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994965/ http://dx.doi.org/10.1007/s13738-021-02235-7

Ejemplares similares

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
por: Hou, Ningke, et al.
Publicado: (2023)

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
por: Rizzuti, Bruno, et al.
Publicado: (2021)

Synthesis, cytotoxic assessment, and molecular docking studies of 2,6-diaryl-substituted pyridine and 3,4- dihydropyrimidine-2(1H)-one scaffolds
por: HOSSEINZADEH, Zahra, et al.
Publicado: (2020)

Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022)

Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays
por: Mazzolari, Angelica, et al.
Publicado: (2020)

3CLpro inhibitors: DEL-based molecular generation
por: Xiong, Feng, et al.
Publicado: (2022)

Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening
por: Córdova-Bahena, Luis, et al.
Publicado: (2021)

Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
por: Paul, Abhik, et al.
Publicado: (2021)

Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
por: Atanasova, Mariyana, et al.
Publicado: (2022)

Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach
por: Gupta, Yash, et al.
Publicado: (2021)

Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro
por: Bibi, Shabana, et al.
Publicado: (2022)

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
por: Senbabaoglu, Filiz, et al.
Publicado: (2020)

Design of a Schiff Base Complex of Copper Coated on Epoxy-Modified Core–Shell MNPs as an Environmentally Friendly and Novel Catalyst for the One-Pot Synthesis of Various Chromene-Annulated Heterocycles
por: Rezayati, Sobhan, et al.
Publicado: (2021)

Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2008)

SO(3)H-Functionalized Epoxy-Immobilized Fe(3)O(4) Core–Shell Magnetic Nanoparticles as an Efficient, Reusable, and Eco-Friendly Catalyst for the Sustainable and Green Synthesis of Pyran and Pyrrolidinone Derivatives
por: Kalantari, Fatemeh, et al.
Publicado: (2023)

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
por: Abian, Olga, et al.
Publicado: (2020)

Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach
por: Agarwal, Garima, et al.
Publicado: (2019)

An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
por: Liao, Qi, et al.
Publicado: (2021)

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant'Anna, Ricardo, et al.
Publicado: (2016)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening
por: Diao, Yanyan, et al.
Publicado: (2018)

DRUG-REPOSITIONING SCREENING IDENTIFIED PIPERLONGUMINE AS A DIRECT STAT3 INHIBITOR WITH POTENT ACTIVITY AGAINST BREAST CANCER
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Target-Based Virtual Screening of Natural Compounds Identifies a Potent Antimalarial With Selective Falcipain-2 Inhibitory Activity
por: Uddin, Amad, et al.
Publicado: (2022)

Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors
por: Scholle, Michael D., et al.
Publicado: (2022)

Repositioning Natural Antioxidants for Therapeutic Applications in Tissue Engineering
por: Marrazzo, Pasquale, et al.
Publicado: (2020)

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
por: Palos, Isidro, et al.
Publicado: (2017)

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2020)

Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
por: Hartini, Yustina, et al.
Publicado: (2021)

Natural Perylenequinone Compounds as Potent Inhibitors of Schistosoma mansoni Glutathione S-Transferase
por: Otarigho, Benson, et al.
Publicado: (2023)

Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
por: Afzaal, Hasan, et al.
Publicado: (2022)

New classes of potent heparanase inhibitors from ligand-based virtual screening
por: Pala, Daniele, et al.
Publicado: (2020)

Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant’Anna, Ricardo, et al.
Publicado: (2023)

siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
por: Perwitasari, Olivia, et al.
Publicado: (2013)

Biocomputational Assessment of Natural Compounds as a Potent Inhibitor to Quorum Sensors in Ralstonia solanacearum
por: Kumar, Sunil, et al.
Publicado: (2022)

Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)
por: Rothan, Hussin A., et al.
Publicado: (2021)

Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets
por: Lagarde, Nathalie, et al.
Publicado: (2018)

QSAR-Based Virtual Screening of Natural Products Database for Identification of Potent Antimalarial Hits
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2021)

Transcriptomics-Based Repositioning of Natural Compound, Eudesmin, as a PRC2 Modulator
por: Yi, Sang Ah, et al.
Publicado: (2021)

Binding profile of protein–ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening
por: Shallangwa, Gideon Adamu, et al.
Publicado: (2021)

Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells
por: Aguirre-Alvarado, Charmina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kehndegolbm1vcrt1s63sbj2ca